InsiderFlow

J. Christopher Naftzger

ABUS

J. Christopher Naftzger serves as General Counsel and CCO at Arbutus Biopharma Corporation (ABUS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$37.2K

Net Position

Net Seller

$37.2K

Companies Traded

1

ABUS

Active Period

Feb 2025

1 total trades

Most Recent

Sell ABUS

Feb 4, 2025 · $37.2K

J. Christopher Naftzger's Insider Trading at Arbutus Biopharma Corporation (ABUS)

Buys

0 · $0.00

Sells

1 · $37.2K

Total Shares Bought

0

Total Shares Sold

11,333

ABUS Price Chart
Loading chart...
DateTypeValue
Feb 4, 2025 Sell$37.2K